1. Home
  2. ARTV vs DTST Comparison

ARTV vs DTST Comparison

Compare ARTV & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTV
  • DTST
  • Stock Information
  • Founded
  • ARTV 2019
  • DTST 2001
  • Country
  • ARTV United States
  • DTST United States
  • Employees
  • ARTV N/A
  • DTST N/A
  • Industry
  • ARTV
  • DTST EDP Services
  • Sector
  • ARTV
  • DTST Technology
  • Exchange
  • ARTV NYSE
  • DTST Nasdaq
  • Market Cap
  • ARTV 41.2M
  • DTST 33.4M
  • IPO Year
  • ARTV 2024
  • DTST N/A
  • Fundamental
  • Price
  • ARTV $3.60
  • DTST $4.68
  • Analyst Decision
  • ARTV Strong Buy
  • DTST
  • Analyst Count
  • ARTV 8
  • DTST 0
  • Target Price
  • ARTV $18.14
  • DTST N/A
  • AVG Volume (30 Days)
  • ARTV 373.8K
  • DTST 970.0K
  • Earning Date
  • ARTV 08-28-2025
  • DTST 08-13-2025
  • Dividend Yield
  • ARTV N/A
  • DTST N/A
  • EPS Growth
  • ARTV N/A
  • DTST N/A
  • EPS
  • ARTV N/A
  • DTST 0.02
  • Revenue
  • ARTV N/A
  • DTST $25,219,312.00
  • Revenue This Year
  • ARTV N/A
  • DTST $12.57
  • Revenue Next Year
  • ARTV N/A
  • DTST $9.29
  • P/E Ratio
  • ARTV N/A
  • DTST $196.98
  • Revenue Growth
  • ARTV N/A
  • DTST N/A
  • 52 Week Low
  • ARTV $1.47
  • DTST $2.93
  • 52 Week High
  • ARTV $17.31
  • DTST $5.85
  • Technical
  • Relative Strength Index (RSI)
  • ARTV N/A
  • DTST 60.09
  • Support Level
  • ARTV N/A
  • DTST $4.68
  • Resistance Level
  • ARTV N/A
  • DTST $5.42
  • Average True Range (ATR)
  • ARTV 0.00
  • DTST 0.31
  • MACD
  • ARTV 0.00
  • DTST 0.11
  • Stochastic Oscillator
  • ARTV 0.00
  • DTST 63.64

About ARTV ARTIVA BIOTHERAPEUTICS INC

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

Share on Social Networks: